From a mechanistic point of view, recent work from the literature also suggested that Aca eradicates CML cells by suppressing activation of the mTOR pathway in BCR-ABL expressing cells [22]. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.